| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
28,040,000 |
| Market
Cap: |
56.92(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.08 - $3.86 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 12.1 |
| Insider 6 Months : 12.1 |
| Insider 3/6 Months : 24.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of immune modulator product candidates to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. Co.'s lead product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73. Co.'s next product candidate, CPI-818, is a selective, covalent inhibitor of ITK and is in a multi-center Phase 1/1b clinical trial in patients with various malignant T-cell lymphomas. Co.'s third product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
597,634 |
597,634 |
607,634 |
782,524 |
| Total Buy Value |
$1,034,624 |
$1,034,624 |
$1,059,124 |
$1,196,645 |
| Total People Bought |
2 |
2 |
3 |
4 |
| Total Buy Transactions |
2 |
2 |
3 |
14 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-09 |
2023-11-08 |
2023-05-10 |
2022-05-10 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Thompson Peter A |
Director |
– • • |
2016-03-29 |
4 |
B |
$15.00 |
$8,250,000 |
I/I |
550,000 |
5,258,450 |
2.25 |
- |
|
| Thompson Peter A |
Director |
– • • |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,708,450 |
4,708,450 |
|
- |
|
| Adams Street Partners Llc |
10% Owner |
– – • |
2016-03-29 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
736,033 |
1.5 |
- |
|
| Adams Street Partners Llc |
10% Owner |
– – • |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,487,381 |
681,256 |
|
- |
|
| Miller Richard A Md |
President and CEO |
• • – |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
328,765 |
1,046,993 |
|
- |
|
| Lea Leiv |
Chief Financial Officer |
• – – |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
42,608 |
199,253 |
|
- |
|
| Gould Terry P |
Director |
– • • |
2016-03-29 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
736,033 |
2.25 |
- |
|
| Gould Terry P |
Director |
– • • |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,487,381 |
681,256 |
|
- |
|
| Verner Erik J. |
V.P., Chemistry ResearchOffice |
• – – |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,773 |
|
- |
|
| Jones William Benton |
VP Pharmaceutical DevelopmentO |
• – – |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
113,773 |
|
- |
|
| Lea Leiv |
Chief Financial OfficerOfficer |
• – – |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
156,645 |
|
- |
|
| Miller Richard A Md |
President and CEOOfficer |
• • – |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
718,228 |
|
- |
|
112 Records found
|
|
Page 5 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (3.57%) 
